PEGylation and glycosylation as bioconjugation tools for drug development: New webinar tackles complex chemistry for targeted ...

While established US biotech hubs may still rule the roost, emerging competitors are looking to grab a larger slice of the ...

Trump MFN drug pricing deal allows Americans to access select branded medications for up to 80% less than list price.

Johnson & Johnson (J&J) is in discussions to purchase Protagonist Therapeutics, as reported by The Wall Street Journal.

The latest amendment, which has been endorsed by Congress, could be the Act’s catalyst after a year in legislative limbo.

Teva and Medincell have secured FDA approval for Uzedy (risperidone), a once-a-month extended-release injectable suspension.

Owen Mumford has unveiled a new addition to its range of medical devices at PDA: The Universe of Pre-Filled Syringes and Injection Devices event in Vienna. Presented for the first time, UniSafe is a ...

BMS, which already has two FDA-approved CAR T-cell therapies, is eyeing entry into the growing in vivo market.

The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ fully human monoclonal antibody ...

Though the FDA will continue its core activities, the agency will no longer be accepting NDAs and BLAs until the ...

Illuminating its plans, neurological disease specialist MapLight said it would offer 14,750,000 shares of its common stock at ...

Amazon Pharmacy kiosks will stock commonly used drugs such as antibiotics, inhalers, and blood pressure medications.